BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Squarespace, Inc. (NYSE – SQSP), PlayAGS, Incorporated (NYSE – AGS), HashiCorp Inc. (Nasdaq – HCP), Deciphera Pharmaceuticals, Inc. (Nasdaq – DCPH)
BALA CYNWYD, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
Squarespace, Inc. (NYSE – SQSP)
Under the terms of the agreement, Squarespace will be acquired by Permira for $44.00 per share in cash representing a transaction valued at over $6.6 billion on an equity value basis and approximately $6.9 billion on an enterprise value basis. The investigation concerns whether the Squarespace Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration offers fair value to the Company’s shareholders.
Additional information can be found at https://www.brodskysmith.com/cases/squarespace-inc-nyse-sqsp/.
PlayAGS, Incorporated (NYSE – AGS)
Under the terms of the agreement, AGS will be acquired by affiliates of Brightstar Capital Partners (“Brightstar”) for $12.50 per share in cash. The investigation concerns whether the AGS Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration offers fair value to the Company’s shareholders.
Additional information can be found at https://www.brodskysmith.com/cases/playags-incorporated-nyse-ags/.
HashiCorp Inc. (Nasdaq – HCP)
Under the terms of the agreement, HashiCorp will be acquired by IBM (NYSE – IBM). IBM will acquire all outstanding shares of HashiCorp common stock for $35.00 per share in cash, for an enterprise value of $6.4 billion. The investigation concerns whether the HashiCorp Group Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether IBM is paying fair value to shareholders of the Company.
Additional information can be found at https://www.brodskysmith.com/cases/hashicorp-inc-nasdaq-hcp/.
Deciphera Pharmaceuticals, Inc. (Nasdaq – DCPH)
Under the terms of the agreement, Deciphera will be acquired by ONO Pharmaceutical Co., Ltd. (“ONO”). ONO will acquire all outstanding shares of Deciphera common stock for $25.60 per share in cash, for a total equity value of $2.4 billion. The investigation concerns whether the Deciphera Group Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether ONO is paying fair value to shareholders of the Company.
Additional information can be found at https://www.brodskysmith.com/cases/deciphera-pharmaceuticals-inc-nasdaq-dcph/.
Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.
-
What Does Nvidia’s Stock Split Mean for Investors?
-
5 Undervalued Stocks to Buy as Their Stories Play Out
-
Markets Brief: Return of the Meme Stocks
-
What’s Happening In the Markets This Week
-
It’s Been a Terrible Time for Bonds. Here’s Why You Should Own Them
-
Which AI Stocks Are Turning Hype Into Revenue?
-
Best- and Worst-Performing Stocks of May 2024
-
3 Stocks to Buy and 3 Stocks to Sell in June
-
Oracle Earnings: IaaS Signings More Than Make Up for Miss
-
This Undervalued Stock Is a Buy After Its Dividend Increase
-
After Earnings, Is Nio Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Lululemon Stock a Buy, a Sell, or Fairly Valued?
-
The 10 Best Dividend Stocks
-
The Most Attractive Investment Opportunities in Oil & Gas
-
Apple: Generative AI Strategy Should Drive Sales and Upgrades
-
2 Undervalued Stocks That Just Raised Dividends